Semaglutide (Wegovy/Ozempic, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk) made up 31.4% and 35.3% of all new GLP-1 receptor agonist prescriptions in 2019, respectively
Whats more, a recent retrospective, multicenter cohort study denied higher occurrence of nonarteritic anterior ischemic optic neuropathy (NAION) in GLP-1RAs users and suggested that its potential benefits for blood glucose control and cardiovascular health likely outweigh its risks (Table 1
Results may vary from person to person, but heres what many of our customers experience: 12 months: Less hair fall - fewer strands in the shower or brush, and a calmer scalp
During periods of intense exercise, L-Glutamine levels can be depleted which may limit protein synthesis
Each of these drugs is slightly different, but all of them are what is known as GLP-1 agonists. In laymans terms, these drugs mimic the hormone that tells our bodies it is time to produce more insulin after you eat
Recent advances in the genetics of mitochondrial encephalopathies
